Inventor · disambiguated record
Karen Duff
Also filed as: DUFF KAREN
7 granted patents·5 pending applications·75 citations·filing 1997–2020
81Inventor score
Top patents by PatentIndex Score
12 records- 0188US7161060B1Transgenic mice comprising a genomic human tau transgeneRES FOUND MENTAL HYGIENE·Filed 2003·Granted Jan 9, 2007·22 cites·6 claims
- 0284US5898094ATransgenic mice expressing APPK670N,M671L and a mutant presenilin transgenesUNIV SOUTH FLORIDA·Filed 1997·Granted Apr 27, 1999·53 cites·14 claims
- 0370US11261199B2Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2020·Granted Mar 1, 2022·0 cites·14 claims
- 0467US11230558B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2018·Granted Jan 25, 2022·0 cites·23 claims
- 0567US11008341B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2018·Granted May 18, 2021·0 cites·23 claims
- 0667US10865214B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2018·Granted Dec 15, 2020·0 cites·19 claims
- 0763US10487091B2Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2017·Granted Nov 26, 2019·0 cites·13 claims
- 0857US2019112317A1Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathiesUNIV COLUMBIA·Filed 2016·Application pending·0 cites
- 0952US2007118915A1Transgenic mice comprising a genomic human tau transgeneMENTAL HYGIENE INC·Filed 2006·Application pending·0 cites
- 1045US2003131364A1Method for producing transgenic animal models with modulated phenotype and animals produced therefromFiled 2003·Application pending·0 cites
- 1142US2005227941A1Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseasesDUFF KAREN·Filed 2002·Application pending·0 cites
- 1241US2003115621A1Transgenic mice comprising a genomic human tau transgeneFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →